Fibroblast Senescence as a Therapeutic Target of Myocardial Fibrosis: Beyond Spironolactone?

A major pathophysiological component of cardiac remodeling during heart failure (HF), cardiac fibrosis has become a target for therapeutic intervention. Additionally, compelling evidence indicates a key role of cardiac fibrosis in myocardial malfunctioning during aging. Cardiac fibrosis is a complex